APA (7th ed.) Citation

SM, F., MW, F., DH, H., JR, Z., LM, V., JA, R., . . . SC, P. (2025). Dominant negative ATP5F1A variants disrupt oxidative phosphorylation causing neurological disorders. EMBO molecular medicine, 17(10), 2562. https://doi.org/10.1038/s44321-025-00290-8

Chicago Style (17th ed.) Citation

SM, Fielder, et al. "Dominant Negative ATP5F1A Variants Disrupt Oxidative Phosphorylation Causing Neurological Disorders." EMBO Molecular Medicine 17, no. 10 (2025): 2562. https://doi.org/10.1038/s44321-025-00290-8.

MLA (9th ed.) Citation

SM, Fielder, et al. "Dominant Negative ATP5F1A Variants Disrupt Oxidative Phosphorylation Causing Neurological Disorders." EMBO Molecular Medicine, vol. 17, no. 10, 2025, p. 2562, https://doi.org/10.1038/s44321-025-00290-8.